Home
Storia in 1 fonti
Bulls Pile Into Moderna As FDA Decision Nears, Ignites 60% Surge In This ETF - Moderna (NASDAQ:MRNA), Def
Moderna shares have surged nearly 30% in five days, ahead of a key FDA advisory vote on its flu vaccine, lifting the leveraged MRNX ETF more than 60%.
Raccontata da
benzinga.com
Timeline cronologica
- ·
FDA Panel Set To Debate Moderna Flu Shot - Moderna (NASDAQ:MRNA)
Moderna flu vaccine faces a key FDA advisory panel review as analysts weigh approval odds, postmarketing study costs, and growth potential.
- ·
Bulls Pile Into Moderna As FDA Decision Nears, Ignites 60% Surge In This ETF - Moderna (NASDAQ:MRNA), Def
Moderna shares have surged nearly 30% in five days, ahead of a key FDA advisory vote on its flu vaccine, lifting the leveraged MRNX ETF more than 60%.
- ·
Moderna's Flu Vaccine Clears Key FDA Panel Vote As Advisory Committee Backs Shot 9-0 - Moderna (NASDAQ:MR
Moderna’s experimental flu vaccine won unanimous FDA panel backing ahead of an Aug. 5 decision.